Anti-cancer

Imatinib Mesylate

Also known as: Imatinib, Imatinib Mesilate

CAS No. 220127-57-1

A tyrosine kinase inhibitor used in oral oncology formulations for chronic myeloid leukemia and gastrointestinal stromal tumors.

Imatinib Mesylate is a first-in-class tyrosine kinase inhibitor oncology API manufactured by NovaAcura Biotech under strict GMP quality systems. Full batch documentation and regulatory support are available for global oncology formulation partners.

Applications & Uses

A tyrosine kinase inhibitor used in oral oncology formulations for chronic myeloid leukemia and gastrointestinal stromal tumors.

Full technical documentation, batch specifications and regulatory support (DMF/CEP) are available on request.

Need This Molecule at Scale?

Get in touch for pricing, lead times and full regulatory documentation.

Get In Touch